These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 25003616)
1. Nephrotic syndrome: Rituximab is safe and effective in FRNS and SDNS--but where to go from here? Razzak M Nat Rev Nephrol; 2014 Aug; 10(8):421. PubMed ID: 25003616 [No Abstract] [Full Text] [Related]
2. Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial. Iijima K; Sako M; Nozu K; Mori R; Tuchida N; Kamei K; Miura K; Aya K; Nakanishi K; Ohtomo Y; Takahashi S; Tanaka R; Kaito H; Nakamura H; Ishikura K; Ito S; Ohashi Y; Lancet; 2014 Oct; 384(9950):1273-81. PubMed ID: 24965823 [TBL] [Abstract][Full Text] [Related]
11. Rituximab for Steroid-Dependent or Frequently Relapsing Idiopathic Nephrotic Syndrome in Adults: A Retrospective, Multicenter Study in Spain. DaSilva I; Huerta A; Quintana L; Redondo B; Iglesias E; Draibe J; Praga M; Ballarín J; Díaz-Encarnación M; BioDrugs; 2017 Jun; 31(3):239-249. PubMed ID: 28534103 [TBL] [Abstract][Full Text] [Related]
12. Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome. Ravani P; Ponticelli A; Siciliano C; Fornoni A; Magnasco A; Sica F; Bodria M; Caridi G; Wei C; Belingheri M; Ghio L; Merscher-Gomez S; Edefonti A; Pasini A; Montini G; Murtas C; Wang X; Muruve D; Vaglio A; Martorana D; Pani A; Scolari F; Reiser J; Ghiggeri GM Kidney Int; 2013 Nov; 84(5):1025-33. PubMed ID: 23739238 [TBL] [Abstract][Full Text] [Related]
13. Rituximab in steroid-sensitive nephrotic syndrome: lessons from clinical trials. Iijima K; Sako M; Kamei K; Nozu K Pediatr Nephrol; 2018 Sep; 33(9):1449-1455. PubMed ID: 28717938 [TBL] [Abstract][Full Text] [Related]
14. Study protocol: mycophenolate mofetil as maintenance therapy after rituximab treatment for childhood-onset, complicated, frequently-relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicenter double-blind, randomized, placebo-controlled trial (JSKDC07). Horinouchi T; Sako M; Nakanishi K; Ishikura K; Ito S; Nakamura H; Oba MS; Nozu K; Iijima K BMC Nephrol; 2018 Nov; 19(1):302. PubMed ID: 30382824 [TBL] [Abstract][Full Text] [Related]
15. [Long-term prognosis of patients with steroid-dependent nephrotic syndrome treated with rituximab]. Kamei K; Okada M; Miyazono A; Sato M; Fujimaru T; Ogura M; Ito S Nihon Jinzo Gakkai Shi; 2013; 55(5):947-55. PubMed ID: 23980480 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of rituximab therapy in children with refractory nephrotic syndrome: a prospective observational study in Shanghai. Sun L; Xu H; Shen Q; Cao Q; Rao J; Liu HM; Fang XY; Zhou LJ World J Pediatr; 2014 Feb; 10(1):59-63. PubMed ID: 24464665 [TBL] [Abstract][Full Text] [Related]